Rare diseases
Investigational molecules
Locations
Ul. Botaniczna 20, 80-298 Gdansk, Poland
Poltreg S.A. focuses on presymptomatic type 1 diabetes in pediatric patients, with research centered on early immune intervention in stage 1 disease.
The sponsor’s clinical interest includes immune-targeted approaches intended to address the onset of islet autoimmunity before clinical diabetes develops.
Poltreg S.A. runs clinical trials in conditions such as Glucose tolerance impaired, among others.
Clinical trials run by this sponsor – those enrolling participants first.
PolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
